SEI Investments
AKBA icon

SEI Investments’s Akebia Therapeutics AKBA Stock Holding History

SEI Investments’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$69.4K Hold
49,934
– – ﹤0.01% 3145
2025
Q4 		$80.4K Sell
49,934
-6,566
-12% -$13.7K ﹤0.01% 3036
2025
Q3 		$154K Sell
56,500
-134,745
-70% -$448K ﹤0.01% 2661
2025
Q2 		$696K Buy
191,245
+16,200
+9% +$44.5K ﹤0.01% 2064
2025
Q1 		$336K Buy
+175,045
New +$357K ﹤0.01% 2295
2021
Q1 		– Sell
-14,231
Closed -$37K – 2469
2020
Q4 		$37K Sell
14,231
-1,405
-9% -$4.1K ﹤0.01% 2442
2020
Q3 		$38K Sell
15,636
-34,180
-69% -$300K ﹤0.01% 2381
2020
Q2 		$675K Buy
49,816
+36,727
+281% +$380K ﹤0.01% 1722
2020
Q1 		$97K Sell
13,089
-58
-0.4% -$451 ﹤0.01% 2260
2019
Q4 		$81K Buy
13,147
+1,279
+11% +$6.08K ﹤0.01% 2344
2019
Q3 		$45K Buy
+11,868
New +$50.9K ﹤0.01% 2349
2019
Q2 		– Sell
-8,661
Closed -$67K – 2384
2019
Q1 		$67K Sell
8,661
-29,062
-77% -$199K ﹤0.01% 2562
2018
Q4 		$206K Buy
+37,723
New +$295K ﹤0.01% 2018
2018
Q2 		– Sell
-1,610
Closed -$15K – 3603
2018
Q1 		$15K Buy
1,610
+545
+51% +$7.62K ﹤0.01% 2736
2017
Q4 		$16K Buy
1,065
+519
+95% +$8.61K ﹤0.01% 2664
2017
Q3 		$11K Buy
+546
New +$8.39K ﹤0.01% 2659

Other funds holding AKBA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

SEI Investments's AKBA Position: Q1 2026 in Review

SEI Investments held its Akebia Therapeutics (AKBA) position steady in Q1 2026 at 49,934 shares worth $69.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3145.

SEI Investments first reported a position in AKBA in Q3 2017 and has held it in 16 quarters since. The position peaked at $696K in Q2 2025. 171 funds tracked by Wall St. Rank hold AKBA as of Q1 2026.

  • SEI Investments held 49,934 shares of Akebia Therapeutics worth $69.4K as of Q1 2026.
  • SEI Investments left its Akebia Therapeutics share count unchanged in Q1 2026.
  • Akebia Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q1 2026, its #3145 holding.
  • SEI Investments first reported a position in Akebia Therapeutics in Q3 2017 and has held it in 16 quarters since.
  • SEI Investments's Akebia Therapeutics position peaked at $696K in Q2 2025.
  • 171 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q1 2026.

Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.